AIN
Cellular Rejuvenation

Cellular Rejuvenation

location_on Midwest ,  United States

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Eden Bloom combines medical-grade regenerative science with aesthetics through a patented exosome hydrogel mask used after RF microneedling. We deliver real anti-aging results at the cellular level while building a scalable, high-margin medispa model

Highlights

  • Clinically proven exosome tech with strong market demand.
  • High-margin regenerative aesthetic product line.
  • Unique IP: exosome-FGF hydrogel optimized for RF uptake.
  • Fast commercialization via U.S. CDMO manufacturing.
  • Scalable model: clinics, medspas, and global distribution.

Overview

Target ZAR 6,100,000
Minimum ZAR 2,000
Investment Raised ZAR 0
Previous Rounds ZAR 0
Stage Pre-Startup/R&D
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects